Sphingosine-1-phosphate receptor 2

FEBS Journal

Volumn 280, Issue 24, 2013, Pages 6354-6366

  Adada, Mohamad ^a   Canals, Daniel ^a   Hannun, Yusuf A ^a   Obeid, Lina M ^a,b  

^a STONY BROOK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

cancer; ceramide; ezrin; JTE013; S1P knockout mouse; S1PR2; SID46371153; sphingolipid diseases; sphingolipids; sphingosine 1 phosphate

Indexed keywords

4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; EZRIN; FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE P38; MOESIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN GALPHAI; PROTEIN KINASE B; RAC PROTEIN; RADIXIN; RAS PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SID 46371153; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; SPHINGOSINE 1 PHOSPHATE RECEPTOR 4; SPHINGOSINE 1 PHOSPHATE RECEPTOR 5; TRANSCRIPTION FACTOR T BET; UBIQUITIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; URINARY TRACT AGENT;

ACUTE LUNG INJURY; ANAPHYLAXIS; ATHEROSCLEROSIS; BLADDER CANCER; BLOOD VESSEL PERMEABILITY; BREAST CANCER; BREAST METASTASIS; CANCER INHIBITION; CARCINOGENESIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CHRONIC MYELOID LEUKEMIA; COLITIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG TARGETING; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HELPER CELL; HUMAN; INFLAMMATION; KIDNEY FUNCTION; LETHALITY; LEWIS CARCINOMA; LIVER CIRRHOSIS; LUNG CANCER; LUNG METASTASIS; LYMPHANGIOGENESIS; MELANOMA METASTASIS; MULTIPLE SCLEROSIS; MUSCLE FUNCTION; NEPHROBLASTOMA; NERVE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; RENAL PROTECTION; REPERFUSION INJURY; RETINOPATHY; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SIGNAL TRANSDUCTION; TH2 CELL; TISSUE DISTRIBUTION; TUMOR GROWTH; TUMOR PROMOTION; TUMOR VASCULARIZATION; VASCULAR RESISTANCE; WOUND HEALING IMPAIRMENT;

CANCER; CERAMIDE; EZRIN; JTE013; S1P KNOCKOUT MOUSE; S1PR2; SID46371153; SPHINGOLIPID DISEASES; SPHINGOLIPIDS; SPHINGOSINE 1-PHOSPHATE;

ANIMALS; HUMANS; LYSOPHOSPHOLIPIDS; NEOPLASMS; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE;

EID: 84889670659     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12446     Document Type: Review

References (93)

1. Hannun YA, &, Obeid LM, (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9, 139-150.
2. Hannun YA, &, Obeid LM, (2011) Many ceramides. J Biol Chem 286, 27855-27862.
3. Zitomer NC, Mitchell T, Voss KA, Bondy GS, Pruett ST, Garnier-Amblard EC, Liebeskind LS, Park H, Wang E, Sullards MC, et al,. (2009) Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals. J Biol Chem 284, 4786-4795.
4. Penno A, Reilly MM, Houlden H, Laura M, Rentsch K, Niederkofler V, Stoeckli ET, Nicholson G, Eichler F, Brown RH Jr, et al,. (2010) Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem 285, 11178-11187.
5. Lingwood CA, (2011) Glycosphingolipid functions. Cold Spring Harb Perspect Biol 3, doi: 10.1101/cshperspect.a004788.
6. Gault CR, &, Obeid LM, (2011) Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. Crit Rev Biochem Mol Biol 46, 342-351.
7. Spiegel S, &, Milstien S, (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4, 397-407.
8. Taha TA, Argraves KM, &, Obeid LM, (2004) Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy. Biochim Biophys Acta 1682, 48-55.
9. Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, &, Spiegel S, (2006) Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci USA 103, 16394-16399.
10. Boujaoude LC, Bradshaw-Wilder C, Mao C, Cohn J, Ogretmen B, Hannun YA, &, Obeid LM, (2001) Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem 276, 35258-35264.
11. Hisano Y, Kobayashi N, Yamaguchi A, &, Nishi T, (2012) Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS ONE 7, e38941.
12. Goodemote KA, Mattie ME, Berger A, &, Spiegel S, (1995) Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate. J Biol Chem 270, 10272-10277.
13. van Koppen C, Meyer zu Heringdorf M, Laser KT, Zhang C, Jakobs KH, Bunemann M, &, Pott L, (1996) Activation of a high affinity Gi protein-coupled plasma membrane receptor by sphingosine-1-phosphat e J Biol Chem 271, 2082-2087.
14. Hla T, &, Maciag T, (1990) An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J Biol Chem 265, 9308-9313.
15. Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, Menzeleev R, Spiegel S, &, Hla T, (1998) Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279, 1552-1555.
16. Okazaki H, Ishizaka N, Sakurai T, Kurokawa K, Goto K, Kumada M, &, Takuwa Y, (1993) Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system. Biochem Biophys Res Commun 190, 1104-1109.
17. Yamaguchi F, Tokuda M, Hatase O, &, Brenner S, (1996) Molecular cloning of the novel human G protein-coupled receptor (GPCR) gene mapped on chromosome 9. Biochem Biophys Res Commun 227, 608-614.
18. Graler MH, Bernhardt G, &, Lipp M, (1998) EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics 53, 164-169.
19. Spiegel S, (2000) Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors. Ann NY Acad Sci 905, 54-60.
20. Aarthi JJ, Darendeliler MA, &, Pushparaj PN, (2011) Dissecting the role of the S1P/S1PR axis in health and disease. J Dental Res 90, 841-854.
21. Lepley D, Paik JH, Hla T, &, Ferrer F, (2005) The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res 65, 3788-3795.
22. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, &, Cyster JG, (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355-360.
23. Yeh EA, &, Weinstock-Guttman B, (2011) Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis. Adv Ther 28, 270-278.
24. Zhi L, Kim P, Thompson BD, Pitsillides C, Bankovich AJ, Yun SH, Lin CP, Cyster JG, &, Wu MX, (2011) FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus. J Immunol 187, 2244-2251.
25. Brinkmann V, Cyster JG, &, Hla T, (2004) FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4, 1019-1025.
26. 2+ signaling pathways. Blood 112, 1129-1138.
27. Kitano M, Hla T, Sekiguchi M, Kawahito Y, Yoshimura R, Miyazawa K, Iwasaki T, Sano H, Saba JD, &, Tam YY, (2006) Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression. Arthr Rheum 54, 742-753.
28. Shimizu T, Nakazawa T, Cho A, Dastvan F, Shilling D, Daum G, &, Reidy MA, (2007) Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries. Circ Res 101, 995-1000.
29. Li MH, Sanchez T, Yamase H, Hla T, Oo ML, Pappalardo A, Lynch KR, Lin CY, &, Ferrer F, (2009) S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. Cancer Lett 276, 171-179.
30. Chae SS, Paik JH, Furneaux H, &, Hla T, (2004) Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest 114, 1082-1089.
31. Bajwa A, Huang L, Ye H, Dondeti K, Song S, Rosin DL, Lynch KR, Lobo PI, Li L, &, Okusa MD, (2012) Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury. J Immunol 189, 2584-2596.
32. Van Doorn R, Van Horssen J, Verzijl D, Witte M, Ronken E, Van Het Hof B, Lakeman K, Dijkstra CD, Van Der Valk P, Reijerkerk A, et al,. (2010) Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions. Glia 58, 1465-1476.
33. Fischer I, Alliod C, Martinier N, Newcombe J, Brana C, &, Pouly S, (2011) Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions. PLoS ONE 6, e23905.
34. Sun X, Singleton PA, Letsiou E, Zhao J, Belvitch P, Sammani S, Chiang ET, Moreno-Vinasco L, Wade MS, Zhou T, et al,. (2012) Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury. Am J Resp Cell Mol Biol 47, 628-636.
35. Keul P, Lucke S, von Wnuck Lipinski K, Bode C, Graler M, Heusch G, &, Levkau B, (2011) Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ Res 108, 314-323.
36. Murakami A, Takasugi H, Ohnuma S, Koide Y, Sakurai A, Takeda S, Hasegawa T, Sasamori J, Konno T, Hayashi K, et al,. (2010) Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. Mol Pharmacol 77, 704-713.
37. Hsu A, Zhang W, Lee JF, An J, Ekambaram P, Liu J, Honn KV, Klinge CM, &, Lee MJ, (2012) Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells. Int J Oncol 40, 1619-1626.
38. Sukocheva O, Wadham C, Holmes A, Albanese N, Verrier E, Feng F, Bernal A, Derian CK, Ullrich A, Vadas MA, et al,. (2006) Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol 173, 301-310.
39. Graler MH, Grosse R, Kusch A, Kremmer E, Gudermann T, &, Lipp M, (2003) The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J Cell Biochem 89, 507-519.
40. Wang W, Graeler MH, &, Goetzl EJ, (2005) Type 4 sphingosine 1-phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J 19, 1731-1733.
41. Schulze T, Golfier S, Tabeling C, Rabel K, Graler MH, Witzenrath M, &, Lipp M, (2011) Sphingosine-1-phospate receptor 4 (S1P(4)) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J 25, 4024-4036.
42. Jaillard C, Harrison S, Stankoff B, Aigrot MS, Calver AR, Duddy G, Walsh FS, Pangalos MN, Arimura N, Kaibuchi K, et al,. (2005) Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J Neurosci 25, 1459-1469.
43. Novgorodov AS, El-Alwani M, Bielawski J, Obeid LM, &, Gudz TI, (2007) Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J 21, 1503-1514.
44. Mayol K, Biajoux V, Marvel J, Balabanian K, &, Walzer T, (2011) Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking. Blood 118, 4863-4871.
45. Jenne CN, Enders A, Rivera R, Watson SR, Bankovich AJ, Pereira JP, Xu Y, Roots CM, Beilke JN, Banerjee A, et al,. (2009) T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med 206, 2469-2481.
46. van Doorn R, Lopes Pinheiro MA, Kooij G, Lakeman K, van het Hof B, van der Pol SM, Geerts D, van Horssen J, van der Valk P, van der Kam E, et al,. (2012) Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier. J Neuroinflammation 9, 133.
47. Chang CL, Ho MC, Lee PH, Hsu CY, Huang WP, &, Lee H, (2009) S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells. Am J Physiol 297, C451-C458.
48. Hu WM, Li L, Jing BQ, Zhao YS, Wang CL, Feng L, &, Xie YE, (2010) Effect of S1P5 on proliferation and migration of human esophageal cancer cells. World J Gastroenterol 16, 1859-1866.
49. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, &, Hla T, (2007) Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscl Throm Vasc 27, 1312-1318.
50. Du J, Zeng C, Li Q, Chen B, Liu H, Huang X, &, Huang Q, (2012) LPS and TNF-alpha induce expression of sphingosine-1-phosphate receptor-2 in human microvascular endothelial cells. Pathology Res Pract 208, 82-88.
51. Lu H, Yuan H, Chen S, Huang L, Xiang H, Yang G, Deng H, &, Zhou J, (2012) Senescent endothelial dysfunction is attributed to the up-regulation of sphingosine-1-phosphate receptor-2 in aged rats. Mol Cell Biochem 363, 217-224.
52. Estrada R, Zeng Q, Lu H, Sarojini H, Lee JF, Mathis SP, Sanchez T, Wang E, Kontos CD, Lin CY, et al,. (2008) Up-regulating sphingosine 1-phosphate receptor-2 signaling impairs chemotactic, wound-healing, and morphogenetic responses in senescent endothelial cells. J Biol Chem 283, 30363-30375.
53. Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, &, Hla T, (2007) Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest 117, 2506-2516.
54. Imasawa T, Koike K, Ishii I, Chun J, &, Yatomi Y, (2010) Blockade of sphingosine 1-phosphate receptor 2 signaling attenuates streptozotocin-induced apoptosis of pancreatic beta-cells. Biochem Biophys Res Commun 392, 207-211.
55. Studer E, Zhou X, Zhao R, Wang Y, Takabe K, Nagahashi M, Pandak WM, Dent P, Spiegel S, Shi R, et al,. (2012) Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology 55, 267-276.
56. Ikeda H, Watanabe N, Ishii I, Shimosawa T, Kume Y, Tomiya T, Inoue Y, Nishikawa T, Ohtomo N, Tanoue Y, et al,. (2009) Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. J Lipid Res 50, 556-564.
57. Oskeritzian CA, Price MM, Hait NC, Kapitonov D, Falanga YT, Morales JK, Ryan JJ, Milstien S, &, Spiegel S, (2010) Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J Exp Med 207, 465-474.
58. Olivera A, Eisner C, Kitamura Y, Dillahunt S, Allende L, Tuymetova G, Watford W, Meylan F, Diesner SC, Li L, et al,. (2010) Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J Clin Invest 120, 1429-1440.
59. Michaud J, Im DS, &, Hla T, (2010) Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation. J Immunol 184, 1475-1483.
60. McQuiston T, Luberto C, &, Del Poeta M, (2011) Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. Microbiology 157, 1416-1427.
61. Takashima S, Sugimoto N, Takuwa N, Okamoto Y, Yoshioka K, Takamura M, Takata S, Kaneko S, &, Takuwa Y, (2008) G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase. Cardiovasc Res 79, 689-697.
62. Grabski AD, Shimizu T, Deou J, Mahoney WM Jr, Reidy MA, &, Daum G, (2009) Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury. Arterioscl Throm Vasc 29, 1644-1650.
63. Loh KC, Leong WI, Carlson ME, Oskouian B, Kumar A, Fyrst H, Zhang M, Proia RL, Hoffman EP, &, Saba JD, (2012) Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. PLoS ONE 7, e37218.
64. Medlin MD, Staus DP, Dubash AD, Taylor JM, &, Mack CP, (2010) Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation. Arterioscl Throm Vasc 30, 1779-1786.
65. Chiba Y, Suzuki K, Uechi M, Kurihara E, Goto K, Sakai H, &, Misawa M, (2010) Downregulation of sphingosine-1-phosphate receptors in bronchial smooth muscle of mouse experimental asthma. Pharmacol Res 62, 357-363.
66. Hoefer J, Azam MA, Kroetsch JT, Leong-Poi H, Momen MA, Voigtlaender-Bolz J, Scherer EQ, Meissner A, Bolz SS, &, Husain M, (2010) Sphingosine-1- phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction. Circ Res 107, 923-933.
67. Meacci E, Cencetti F, Formigli L, Squecco R, Donati C, Tiribilli B, Quercioli F, Zecchi Orlandini S, Francini F, &, Bruni P, (2002) Sphingosine 1-phosphate evokes calcium signals in C2C12 myoblasts via Edg3 and Edg5 receptors. Biochem J 362, 349-357.
68. Kimura A, Ohmori T, Kashiwakura Y, Ohkawa R, Madoiwa S, Mimuro J, Shimazaki K, Hoshino Y, Yatomi Y, &, Sakata Y, (2008) Antagonism of sphingosine 1-phosphate receptor-2 enhances migration of neural progenitor cells toward an area of brain. Stroke 39, 3411-3417.
69. Akahoshi N, Ishizaki Y, Yasuda H, Murashima YL, Shinba T, Goto K, Himi T, Chun J, &, Ishii I, (2011) Frequent spontaneous seizures followed by spatial working memory/anxiety deficits in mice lacking sphingosine 1-phosphate receptor 2. Epilepsy Behav 22, 659-665.
70. Liu W, Lan T, Xie X, Huang K, Peng J, Huang J, Shen X, Liu P, &, Huang H, (2012) S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition. Exp Cell Res 318, 936-943.
71. Park SW, Kim M, Brown KM, D'Agati VD, &, Lee HT, (2012) Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 23, 266-280.
72. Yamaguchi H, Kitayama J, Takuwa N, Arikawa K, Inoki I, Takehara K, Nagawa H, &, Takuwa Y, (2003) Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem J 374, 715-722.
73. Arikawa K, Takuwa N, Yamaguchi H, Sugimoto N, Kitayama J, Nagawa H, Takehara K, &, Takuwa Y, (2003) Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J Biol Chem 278, 32841-32851.
74. Li MH, Sanchez T, Pappalardo A, Lynch KR, Hla T, &, Ferrer F, (2008) Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res 6, 1649-1656.
75. Cattoretti G, Mandelbaum J, Lee N, Chaves AH, Mahler AM, Chadburn A, Dalla-Favera R, Pasqualucci L, &, MacLennan AJ, (2009) Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. Cancer Res 69, 8686-8692.
76. An S, Zheng Y, &, Bleu T, (2000) Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5. J Biol Chem 275, 288-296.
77. Salas A, Ponnusamy S, Senkal CE, Meyers-Needham M, Selvam SP, Saddoughi SA, Apohan E, Sentelle RD, Smith C, Gault CR, et al,. (2011) Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. Blood 117, 5941-5952.
78. Ponnusamy S, Selvam SP, Mehrotra S, Kawamori T, Snider AJ, Obeid LM, Shao Y, Sabbadini R, &, Ogretmen B, (2012) Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. EMBO Mol Med 4, 761-775.
79. Orr Gandy KA, Adada M, Canals D, Carroll B, Roddy P, Hannun YA, &, Obeid LM, (2013) Epidermal growth factor-induced cellular invasion requires sphingosine-1-phosphate/sphingosine-1-phosphate 2 receptor-mediated ezrin activation. FASEB J, doi: 10.1096/fj.13-228460.
80. Takabe K, Paugh SW, Milstien S, &, Spiegel S, (2008) 'Inside-out' signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 60, 181-195.
81. Salomone S, &, Waeber C, (2011) Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects. Front Pharmacol 2, 9.
82. Long JS, Fujiwara Y, Edwards J, Tannahill CL, Tigyi G, Pyne S, &, Pyne NJ, (2010) Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. J Biol Chem 285, 35957-35966.
83. Rosen H, (2011) High throughput screening for S1P receptor agonists and antagonists, S1P2 agonist. The Scripps Molecular Screening Center Probe Report. The Scripps Research Institute Molecular Screening Center, La Jolla, CA.
84. Rivera J, Proia RL, &, Olivera A, (2008) The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 8, 753-763.
85. Graeler M, &, Goetzl EJ, (2002) Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J 16, 1874-1878.
86. Walzer T, Chiossone L, Chaix J, Calver A, Carozzo C, Garrigue-Antar L, Jacques Y, Baratin M, Tomasello E, &, Vivier E, (2007) Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol 8, 1337-1344.
87. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ, et al,. (2000) Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106, 951-961.
88. MacLennan AJ, Carney PR, Zhu WJ, Chaves AH, Garcia J, Grimes JR, Anderson KJ, Roper SN, &, Lee N, (2001) An essential role for the H218/AGR16/Edg-5/LP(B2) sphingosine 1-phosphate receptor in neuronal excitability. Eur J Neurosci 14, 203-209.
89. Lorenz JN, Arend LJ, Robitz R, Paul RJ, &, MacLennan AJ, (2007) Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice. Am J Physiol 292, R440-R446.
90. Kono M, Belyantseva IA, Skoura A, Frolenkov GI, Starost MF, Dreier JL, Lidington D, Bolz SS, Friedman TB, Hla T, et al,. (2007) Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 282, 10690-10696.
91. Ishii I, Friedman B, Ye X, Kawamura S, McGiffert C, Contos JJ, Kingsbury MA, Zhang G, Brown JH, &, Chun J, (2001) Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J Biol Chem 276, 33697-33704.
92. Golfier S, Kondo S, Schulze T, Takeuchi T, Vassileva G, Achtman AH, Graler MH, Abbondanzo SJ, Wiekowski M, Kremmer E, et al,. (2010) Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4. FASEB J 24, 4701-4710.
93. Debien E, Mayol K, Biajoux V, Daussy C, De Aguero MG, Taillardet M, Dagany N, Brinza L, Henry T, Dubois B, et al,. (2013) S1PR5 is pivotal for the homeostasis of patrolling monocytes. Eur J Immunol, doi: 10.1002/eji.201343312.